13 January 2012 - Islet Sciences Inc, a biotech unit of US One E-Commerce Corp (OTCBB:ONCE) with patented transplantation technologies for insulin-dependent diabetes patients, has signed a product manufacturing agreement with Progenitor Cell Therapy (PCT), a cell therapy manufacturing division of Ne...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up